Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Tandem Diabetes Care (TNDM) over the last 14 years, with Q3 2025 value amounting to $257.7 million.

  • Tandem Diabetes Care's Non-Current Assets rose 2577.06% to $257.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 2452.14%. This contributed to the annual value of $243.2 million for FY2024, which is 1880.99% up from last year.
  • According to the latest figures from Q3 2025, Tandem Diabetes Care's Non-Current Assets is $257.7 million, which was up 2577.06% from $260.9 million recorded in Q2 2025.
  • Tandem Diabetes Care's Non-Current Assets' 5-year high stood at $260.9 million during Q2 2025, with a 5-year trough of $92.6 million in Q1 2021.
  • Its 5-year average for Non-Current Assets is $189.1 million, with a median of $202.8 million in 2022.
  • In the last 5 years, Tandem Diabetes Care's Non-Current Assets soared by 12365.73% in 2022 and then tumbled by 1475.12% in 2023.
  • Over the past 5 years, Tandem Diabetes Care's Non-Current Assets (Quarter) stood at $93.6 million in 2021, then surged by 116.64% to $202.8 million in 2022, then rose by 0.92% to $204.7 million in 2023, then grew by 18.81% to $243.2 million in 2024, then rose by 5.98% to $257.7 million in 2025.
  • Its Non-Current Assets was $257.7 million in Q3 2025, compared to $260.9 million in Q2 2025 and $258.7 million in Q1 2025.